Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction

This study has been completed.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
Samsung Medical Center
ClinicalTrials.gov Identifier:
NCT00827814
First received: January 22, 2009
Last updated: June 8, 2009
Last verified: June 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2009
  Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)